Has announced that it too with Health Canada Regulatory Affairs division.

Clinical stage Technologies Discusses Phase I Clinical Trial ApplicationImmunoVaccine Technologies Inc. has announced that it too with Health Canada Regulatory Affairs division, the Biologics and Genetic Therapies Directorate meets the requirements for a Phase I clinical trial application discuss. For Phase I clinical trials scheduled IVT novel antigens with its vaccine – technology to improve … [Read more…]